full list rate price target
earn chang report pleas see
tabl page
relief payment late last week releas guidanc immedi distribut
bn health care relief indic provid hospit dialysi
clinic surgeri center etc share bn equal base alloc
prior year medicar ff revenu confirm notion monday morn
indic alreadi receiv initi alloc mn
ebitda estim given dialysi revenu over-index medicar initi
relief payment good somewhat surpris financi outcom dialysi
compani rel provid like experienc signific
level disrupt show updat relief estim cover provid figur
investor focu shift commerci mix onset crisi suggest
safe-haven stock within hc servic given resili volum compar
low leverag strong stock held rel well signific
spike initi unemploy claim shift investor focu defens
natur dialysi treatment neg implic associ lower
commerci treatment mix potenti sustain perman job loss
look back global crisi dva commerci
treatment mix declin roughli bp interestingli commerci
revenu mix deterior bp time potenti indic
abl negoti higher rate lower commerci membership base
anchor annual shift commerci treatment mix illustr
earn sensit ebitda ebitda figur
note earn impact practic initi stimulu relief
payment moreov cobra remain common option patient lose employer-
base coverag help delay mitig financi harm associ
still defens stock despit declin commerci mix gfc
fare rel well four-year period end
end fundament compani grew revenu annual ep
annual moreov dva stock display strong defens characterist
throughout gfc materi outperform broader market
also max drawdown half spi height crisi put
togeth think initi stimulu relief provid decent financi cushion
help off-set near-term cost weather earli deterior
commerci mix acknowledg potenti greater financi risk
unemploy crisi sustain longer period time reiter
ow rate
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
summari rate price target earn chang report chang shown bold
barclay research share price target price shown primari list currenc ep estim shown report currenc
current fiscal year estim barclay research fiscal year estim barclay research
relief distribut like shield dialysi provid near-
friday releas guidanc immedi distribut bn
stimulu provid addit clariti qualifi money
alloc short appear provid share bn equal base
medicar ff payment given dialysi provid over-index medicar
initi relief payment dialysi provid
ebitda think good financi outcom rel provid
like experienc signific level disrupt
provid distribut portion initi billion base share
total medicar ff reimburs total ff payment approxim
billion
facil provid receiv medicar fee-for-servic ff reimburs
elig initi rapid distribut
condit receiv fund provid must agre seek collect
out-of-pocket payment patient greater patient
would otherwis requir pay care provid in-
monday morn press releas note receiv mn bn
distribut repres ebitda estim howev note
abil util retain full amount depend magnitud time
natur impact well guidelin rule program
yet announc estim receiv mn alloc
ebitda estim
addit note expect receiv mn suspens
medicar sequestr estim benefit mn
mnaradvacyhhcathcuhsff medicar total ff medicar spend per relief aid first relief gross ebitda ebitda ebitda barclay servic
long-term implic sustain unemploy
dialysi provid like okay financi near-term signific spike
initi unemploy claim shift investor focu defens natur
dialysi volum pandem neg implic associ lower
commerci treatment mix potenti sustain job loss
sinc onset pandem april nearli mn peopl file initi
claim unemploy number expect rise come week recent
surg unemploy claim data dwarf histor comparison note major
current claim repres worker temporari laid furlough
mani employe retain health benefit
claim unemploy mn
fred bloomberg actual except continu claim
consensu estim shown
look back global crisi
order frame potenti implic neg commerci mix-shift
current crisi look back period better understand impact
rise unemploy dva commerci treatment revenu mix last
financi crisi yet public
dva commerci treatment mix declin roughli
bp interestingli commerci revenu mix deterior bp time
potenti indic abl negoti higher rate lower commerci
addit commerci treatment mix continu fall even
unemploy start declin like due delay financi effect
extend coverag cobra
commerci option newli unemploy
esrd patient lose employer-bas health coverag gener retain
commerci insur cobra exchang plan spous
insur plan cobra probabl common
cobra insur coverag typic extend month half
qualifi month addit coverag certain disabl rule mani
cobra-choos member abl maintain commerci coverag
coordin period commerci insur remain primari payor
thu cobra potenti significantli delay mitig financi headwind
dialysi provid final cobra expens mani esrd patient may
elig premium assist american kidney fund
addit exchang plan offer altern coverag option exist
last financi crisi loss job-bas health insur allow
special enrol exchang plan nine state run
exchang reopen enrol everyon includ new york california
colorado massachusett plan could viabl altern member
lose health insur coverag think member like extend coverag
cobra
illustr treatment shift commerci government pay
shown earlier dva commerci treatment mix deterior annual
think repres reason framework commerci mix-shift
potenti extend unemploy crisi illustr shift
commerci mix could impact ebitda
earn impact treatment mix-shift
dvaaracommerci revenu per medicar revenu per revenu differenti per total shift impact ebitda gross gross ebitda barclay servic
fundament stock perform gfc
despit declin commerci mix fare rel well four-year period
end end fundament compani grew revenu
annual ep annual moreov dva stock display strong
defens characterist throughout gfc materi outperform
broader market also max drawdown half spi height
crisi
steve valiquett herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
